In Ottawa on September 20, 2012, the Canadian Academy of Health Sciences held a forum entitled, ‘End of Life Care: the Last 100 Days’. Following an opening plenary by Dr. Daren Heyland, presentations and discussions ensued, highlighting recent research, current controversies, and future directions to improve end-of-life care in Canada [1]. Three articles in this issue of Clinical Investigative Medicine build on presentations from that day
